Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-12-03

Clinical Trial Update: Controlled Level EVERolimus in Acute Coronary Syndromes [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for everolimus in acute coronary syndromes across Phase 1 and Phase 2 stages (completed).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Everolimus (everolimus)

Snippet

Sponsor: University of Zurich | Conditions: Acute Coronary Syndromes | Phase 1, Phase 2 | Status: COMPLETED